Breast Cancer Clinical Trial
Official title:
Interactive CD-ROM on Cancer Genetics for Hispanics
This project will build upon prior, successful research on the effectiveness of an
interactive computer disk with readable only memory (CD-ROM) for educating women about
breast cancer and genetic risk. Prior studies found that an interactive CD-ROM for educating
women about breast cancer risk and genetic testing was effective. The program was well
received by lay persons and professionals. In a randomized controlled trial conducted at
multiple sites, the CD-ROM intervention was highly effective in increasing knowledge,
especially among women at low risk of carrying a breast cancer susceptibility gene 1/2
(BRCA1/2) mutation.
Researchers now propose to expand the use of the interactive CD-ROM in two innovative ways.
The overall goal of this proposal is to evaluate the program as a first-line educational
approach for Hispanic women on the Texas-Mexico border, where educational resources about
cancer genetics are limited. First, researchers will modify and adapt the program for a
primarily Hispanic population, in order to make it culturally and linguistically appropriate
to the needs of that audience.
Second, researchers will evaluate the program as a first-line educational method among women
with a personal or family history of breast cancer. Researchers will compare the
effectiveness of the CD-ROM when implemented with and without the guidance of a trained
promotora, and in comparison with standard educational materials (usual care condition).
The specific aims of this study include:
Aim 1: To modify the interactive CD-ROM to: a) make it culturally and linguistically
appropriate for Hispanic women residing along the Texas-Mexico border; b) reflect current
knowledge about breast cancer genetics; c) add a module to help women prepare to discuss
their family history and cancer risk with a health care provider (n=50 participants).
Aim 2: To conduct a randomized, controlled evaluation that compares the efficacy of the
modified CD-ROM when used alone vs. when used with a promotora-assisted approach vs.
standard written materials (n=414 participants).
This study will test ways to help improve Hispanic women's knowledge and understanding about
breast cancer risk and genetic testing for inherited cancer risk. These methods include
providing printed educational materials, using an educational computer program, and using
the computer program with the assistance of a lay health worker (a promotora).
If you agree to take part in this study, you will complete a questionnaire that will ask
about your personal health as well as your knowledge and attitudes toward cancer and genetic
testing. After the questionnaire is completed, you will be randomly assigned (as in the roll
of dice) to 1 of 3 study groups. One group will be asked to read educational materials.
Another group will use an educational computer program to learn about breast cancer risk and
genetic testing without guidance. Another group will use the computer program with the
guidance of a promotora.
Each of the 3 study groups should take between 30 and 60 minutes to complete.
Immediately after participating in your assigned group, you will be asked to complete
another questionnaire that will ask about your knowledge and attitudes toward cancer and
genetic testing. You will also be contacted later by telephone to complete similar
questionnaires at about 1 month and 6 months after your study visit. Some women will be
asked to complete an additional questionnaire by telephone 1 week after reading the
educational materials or the computer program, and researchers will ask for permission to
audiotape this interview. It will take about 20 minutes to complete each of the
questionnaires used in this study.
This is an investigational study. Up to 414 women will take part in this study.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |